WEBTOON Entertainment Inc. Reports Third Quarter 2025 Financial Results

WEBTOON Entertainment Inc. Reports Third Quarter 2025 Financial Results GlobeNewswire November 12, 2025 Delivered Adjusted EBITDA Above Midpoint of Guidance Range Third Quarter Revenue Growth of 8.7%; Revenue Growth on a Constant Currency Basis of 9.1% Net Loss of $11.1 Million; Adjusted EBITDA of $5.1 Million Strong Balance Sheet With Cash and Cash Equivalents of […]

Kyverna Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results

Kyverna Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results GlobeNewswire November 12, 2025 Topline data from registrational trial in stiff person syndrome (SPS) now expected in early 2026; narrowed from previous guidance of first half 2026; BLA submission anticipated in 1H 2026 Positive interim Phase 2 data in generalized myasthenia gravis (gMG);

U.S. Global Investors Announces a Rebound in Profitability in the First Quarter of Fiscal 2026 on Rising Gold Assets and Investment Income

U.S. Global Investors Announces a Rebound in Profitability in the First Quarter of Fiscal 2026 on Rising Gold Assets and Investment Income GlobeNewswire November 12, 2025 SAN ANTONIO, Nov. 12, 2025 (GLOBE NEWSWIRE) — U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a registered investment advisory firm1 with longstanding experience in global markets and specialized

Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress

Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress GlobeNewswire November 12, 2025 Completed strategic pivot from R&D focus to commercial focus Rebranded as Dyadic Applied BioSolutions and launched redesigned website to optimize commercial engagement and investor relations Advanced multiple recombinant protein programs toward commercialization Achieved key development and commercial milestones across life

SoundThinking, Inc. Reports Third Quarter 2025 Financial Results

SoundThinking, Inc. Reports Third Quarter 2025 Financial Results Company Updates FY 2025 Revenue Guidance from $111.0 Million to $113.0 Million to approximately $104.0 Million GlobeNewswire November 12, 2025 FREMONT, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — SoundThinking, Inc. (Nasdaq: SSTI), a leading public safety technology company, today reported financial results for the third quarter ended

Portnoy Law Firm Announces Class Action on Behalf of Telix Pharmaceuticals Limited Investors

(NASDAQ:TLX), LOS ANGELES, Nov. 12, 2025 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Telix Pharmaceuticals Limited, (“Telix” or the “Company”) (NASDAQ: TLX) investors off a class action on behalf of investors that bought securities between February 21, 2025 and August 28, 2025, inclusive (the “Class Period”). Telix investors have until January 9, 2026 to

INNOVATE Corp. Announces Third Quarter 2025 Results

(NYSE:VATE), – Infrastructure: DBM Global delivers robust revenue growth, reinforcing market leadership –– Life Sciences: MediBeacon received regulatory approval to sell the Transdermal GFR System in China –– Spectrum: New network launches underway; Fourth quarter advertising sales showing early signs of recovery – NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) — INNOVATE Corp. (“INNOVATE” or

Portnoy Law Firm Announces Class Action on Behalf of Telix Pharmaceuticals Limited Investors

Portnoy Law Firm Announces Class Action on Behalf of Telix Pharmaceuticals Limited Investors GlobeNewswire November 12, 2025 LOS ANGELES, Nov. 12, 2025 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Telix Pharmaceuticals Limited, (“Telix” or the “Company”) (NASDAQ: TLX) investors off a class action on behalf of investors that bought securities between February 21, 2025

INNOVATE Corp. Announces Third Quarter 2025 Results

INNOVATE Corp. Announces Third Quarter 2025 Results GlobeNewswire November 12, 2025 – Infrastructure: DBM Global delivers robust revenue growth, reinforcing market leadership –– Life Sciences: MediBeacon received regulatory approval to sell the Transdermal GFR System in China –– Spectrum: New network launches underway; Fourth quarter advertising sales showing early signs of recovery – NEW YORK,

Scroll to Top